Nebratamig | Interleukin Related interleukin-related.com

Product Name :
Nebratamig

Search keywords :
ROR1

drugId :
null

Target Vo:
Inactive tyrosine-protein kinase transmembrane receptor ROR1

Target Vo Short Name :
ROR1

Moa_Name:
Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sichuan Baili Pharmaceutical Co Ltd

Active Company_Name :
Sichuan Baili Pharmaceutical Co Ltd

Active Indication_Name:
Lymphoma, Non-Hodgkin

In Active Indication_Name:
Solid tumours

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
COX2 Mouse mAb Purity
Nrf1 Rabbit mAb References
CDX2 Antibody: CDX2 Antibody is an unconjugated, approximately 34 kDa, rabbit-derived, anti-CDX2 monoclonal antibody. CDX2 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts